Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Severe infections in pediatric intensive care unit are not uncommon. Historically, the diagnosis of hereditary (primary) immune deficiency required a combination of recurrent clinical signs and biological stigmas. This paradigm is currently being questioned, and grows the hypothesis of a potential underlying genetic susceptibility in any severe infection. To date, the proportion of severe infections explained by an underlying immune deficiency is unknown. The aim of this prospective study is to assess the incidence of primary immune deficiencies in children with severe infection, regardless of their etiology.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3 months
Maximum Age: 16
Healthy Volunteers: f
View:

• Inclusion age less than 16 years

• Inclusion age \> 3 months of actual age for term infants and \> 3 months for former preterm infants.

• Documented severe infection (bacterial, viral, fungal) at the University Hospital Center of Montpellier, Toulouse or Marseille

• Severe infections concerned by the study: any infection requiring hospitalization in pediatric intensive care (more than 24 hours) including:

• meninges or brain lesions, pleuro-pneumopathy, any infection associated with sepsis and/or an opportunistic germ, septic shock, etc.

• Encephalitis and encephalomyelitis of infectious origin

• Child benefiting from a social security system

• Collection of parental/legal representative consent

Locations
Other Locations
France
Uhmontpellier
RECRUITING
Montpellier
Contact Information
Primary
Eric JEZIORSKI
e-jeziorski@chu-montpellier.fr
04 67 33 57 98
Time Frame
Start Date: 2023-09-04
Estimated Completion Date: 2026-09-04
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Montpellier

This content was sourced from clinicaltrials.gov